Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
Clinical trial NCT07187869 · RECRUITING
Trial details
- NCT number
- NCT07187869
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-12
- Primary completion
- 2027-04-07
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.